QuidelOrtho Corp. Hits Day Low of $13.02 Amid Price Pressure

QuidelOrtho Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 7.01%. The stock reached an intraday low of USD 13.02, reflecting ongoing challenges faced by the company. Over the past year, QuidelOrtho has reported a staggering loss of 53.16%, significantly underperforming the S&P 500, which gained 24.03% during the same period. The company's financial metrics reveal a concerning trend, with a pre-tax profit of USD -73.1 million, marking a decline of 127.37%. Additionally, net profit fell to USD -85.4 million, down 123.71%. QuidelOrtho's operating cash flow has also reached a low of USD 6.6 million, indicating potential liquidity issues. The stock's performance over the last three years has consistently lagged behind the S&P 500, with a cumulative decline of 85.01%. As the company continues to navigate these financial hurdles, its market position remains precarious within the competitive landscape of the pharmaceuticals and biotechnology industry.